[1]
Panibratiuk, O.A. and Yakovleva O.А. 2022. ASSESSMENT OF BLEEDING RISK FACTORS DURING WARFARIN THERAPY IN ISCHEMIC HEART DISEASE COMPLICATED BY ATRIAL FIBRILLATION. Medical and Clinical Chemistry. 2 (Oct. 2022), 24–32. DOI:https://doi.org/10.11603/mcch.2410-681X.2022.i2.13202.